Physician profile
Brianna Michele Wright
NPI 1790334019
$1,016.18
in general payments reported to CMS, 2019-2025
15 companies · $511 in 2025
The $511 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $80.36 · 2022: $87.92 · 2023: $125 · 2024: $212 · 2025: $511.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $763 · Education: $84.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $762.91 |
| Education | $84.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $239.36 | 2025 | Carvykti, Rybrevant, Erleada |
| 180 Medical, INC. | $138.29 | 2022-2025 | Cure Catheter |
| Ethicon US, LLC | $122.85 | 2024 | Stratafix, Echelon Flex, Ethicon |
| Abbvie INC. | $118.40 | 2022-2024 | |
| Endo Pharmaceuticals INC. | $68.84 | 2021-2023 | Xiaflex, Aveed |
| Astellas Pharma US INC | $65.00 | 2021 | |
| Bluewind Medical | $60.00 | 2025 | Revi |
| Teleflex LLC | $39.76 | 2024-2025 | Barrigel, Urolift |
| Boston Scientific Corporation | $33.34 | 2023 | Greenlight Xps |
| Tolmar, INC. | $29.99 | 2025 | Eligard, Jatenzo |
| Endo USA, INC. | $26.64 | 2025 | Xiaflex, Aveed |
| Urogen Pharma, INC. | $24.61 | 2023 | |
| Pfizer INC. | $21.80 | 2025 | |
| Axonics, INC. | $14.35 | 2023 | Axonics, Bulkamid |
| Coloplast Corp | $12.95 | 2023 | Self-Cath |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brianna Wright listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.